Metropolis Healthcare records consolidated revenue growth of 18.1% in FY19

PAT before CSR and one time share based and other expenses @ INR 1308 million in FY19

Business, Metropolis Healthcare

Metropolis Healthcare Ltd (referred to as the “Company”; NSE: METROPOLIS |BSE:  542650) a leading diagnostic service provider announces their financial results for the financial year 2018-19.

Key performance highlights: FY 2018-19 vs. FY 2017-18

Consolidated revenue growth of 18.1% in FY19

EBIDTA before CSR and one-time share based and other expenses  @ INR 2073 million in FY19

PAT before CSR and one time share based and other expenses @ INR 1308 million in FY19

Earnings per Share: INR 24.06

 

 

 

 

 

 

 

Share